← Leaderboards
Yong-Hwan Lee
Louisiana State Univ A&M Col Baton Rouge
$2,008,332
Attributed
$2,008,332
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $289.3K · FY2008–24$500K$375K$250K$125K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,008,332 · 3
By mechanism
R01$1,091,193 · 1
P20$899,714 · 1
P41$17,425 · 1
Top collaborators
No co-investigators on record.
Most similar at Louisiana State Univ A&M Col Baton Rouge
Same institution · by research overlap
- Konstantin G Kousoulas$25,936,565
- Samithamby Jeyaseelan$15,826,681
- Joseph Francis$6,492,338
- Stephania A Cormier$17,268,563
- Tammy R Dugas$8,192,887
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularDatabasesProteinsGeneticBaseUnited States National Institutes Of HealthResearch PersonnelFundingInstitutionResourcesBiologyDrug Delivery SystemsCellular BiologyBiomedical ResearchEducational WorkshopElectron MicroscopyCore FacilityCommunicationAntineoplastic AgentsConsultationsBioinformaticsCaringBiologicalCollaborations
Grant awards (10)
Molecular and Cell Biology Resources Core (MCBRC)$208,495
P20 · FY2024 · GM · contact PI
Molecular and Cell Biology Resources Core (MCBRC)$217,875
P20 · FY2023 · GM · contact PI
Molecular and Cell Biology Resources Core (MCBRC)$194,029
P20 · FY2022 · GM · contact PI
Molecular and Cell Biology Resources Core (MCBRC)$194,031
P20 · FY2021 · GM · contact PI
Molecular and Cell Biology Resources Core (MCBRC)$85,284
P20 · FY2020 · GM · contact PI
PFKFB3-based development of a new cancer drug targeting the Warburg effect$263,743
R01 · FY2011 · CA · contact PI
PFKFB3-based development of a new cancer drug targeting the Warburg effect$271,900
R01 · FY2010 · CA · contact PI
PFKFB3-BASED DEVELOPMENT OF NEW CANCER DRUG TARGETING THE WARBURG EFFECT$17,425
P41 · FY2010 · RR · contact PI
PFKFB3-based development of a new cancer drug targeting the Warburg effect$271,900
R01 · FY2009 · CA · contact PI
PFKFB3-based development of a new cancer drug targeting the Warburg effect$283,650
R01 · FY2008 · CA · contact PI